Cargando…

The respiratory manifestations in patients with primary Sjögren’s syndrome: is interstitial lung disease related to disease activity?

BACKGROUND/AIM: Sjögren’s syndrome is a systemic, autoimmune disease and can affect many organs and systems. In this study, we aimed to evaluate the respiratory manifestations, and the association between interstitial lung disease (ILD) and disease activity in primary SS (pSS) patients. MATERIALS AN...

Descripción completa

Detalles Bibliográficos
Autores principales: ÖZDEMİR IŞIK, Özlem, YAZICI, Ayten, ÇEFLE, Ayşe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395710/
https://www.ncbi.nlm.nih.gov/pubmed/36422505
http://dx.doi.org/10.55730/1300-0144.5513
_version_ 1785083636264992768
author ÖZDEMİR IŞIK, Özlem
YAZICI, Ayten
ÇEFLE, Ayşe
author_facet ÖZDEMİR IŞIK, Özlem
YAZICI, Ayten
ÇEFLE, Ayşe
author_sort ÖZDEMİR IŞIK, Özlem
collection PubMed
description BACKGROUND/AIM: Sjögren’s syndrome is a systemic, autoimmune disease and can affect many organs and systems. In this study, we aimed to evaluate the respiratory manifestations, and the association between interstitial lung disease (ILD) and disease activity in primary SS (pSS) patients. MATERIALS AND METHODS: The study design was retrospective cross-sectional, and 151 patients followed up with a diagnosis of pSS between 2004 and 2019 were included in the study. Demographic and clinical data, laboratory results, chest radiographs and thorax computed tomography (CT) results were obtained from patient files and hospital imaging system. Thorax CT was requested from all patients with respiratory complaints and abnormalities in physical examination and pulmonary function test. Disease activity was calculated with EULAR pSS disease activity index (ESSDAI) and clinical European League Against Rheumatism SS Disease Activity Index (clin-ESSDAI). RESULTS: In our study, 97% of pSS patients were female, and the mean age was 55.9 ± 12 years, disease onset age was 45.5 ± 12.1 years, disease duration was 10.7 (1–38) years. According to CT findings of 120 patients, 35% had nodules, and 13.3% had ILD (62.5% nonspecific interstitial pneumonia, 25% lymphocytic interstitial pneumonia, 12.5% usual interstitial pneumonia). Bronchiectasis, emphysema, sequelae fibrotic changes, and pleural thickening was found in 3.3%, 5.8%, 15.8%, and 1.7% of patients, respectively. It was observed that there was a significant relationship between the presence of ILD and persistent cough, mediastinal LAP, low DLCO, high ESSDAI and clin-ESSDAI scores reflecting disease activity. CONCLUSION: The most common pulmonary manifestation in our patients was ILD. ILD was observed more frequently in patients with moderate and severe disease activity. Some of the ILD patients were diagnosed while they were asymptomatic. Even if they are asymptomatic, it is important to follow up the patients with physical examination, spirometry, DLCO and thorax CT.
format Online
Article
Text
id pubmed-10395710
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Scientific and Technological Research Council of Turkey (TUBITAK)
record_format MEDLINE/PubMed
spelling pubmed-103957102023-08-03 The respiratory manifestations in patients with primary Sjögren’s syndrome: is interstitial lung disease related to disease activity? ÖZDEMİR IŞIK, Özlem YAZICI, Ayten ÇEFLE, Ayşe Turk J Med Sci Research Article BACKGROUND/AIM: Sjögren’s syndrome is a systemic, autoimmune disease and can affect many organs and systems. In this study, we aimed to evaluate the respiratory manifestations, and the association between interstitial lung disease (ILD) and disease activity in primary SS (pSS) patients. MATERIALS AND METHODS: The study design was retrospective cross-sectional, and 151 patients followed up with a diagnosis of pSS between 2004 and 2019 were included in the study. Demographic and clinical data, laboratory results, chest radiographs and thorax computed tomography (CT) results were obtained from patient files and hospital imaging system. Thorax CT was requested from all patients with respiratory complaints and abnormalities in physical examination and pulmonary function test. Disease activity was calculated with EULAR pSS disease activity index (ESSDAI) and clinical European League Against Rheumatism SS Disease Activity Index (clin-ESSDAI). RESULTS: In our study, 97% of pSS patients were female, and the mean age was 55.9 ± 12 years, disease onset age was 45.5 ± 12.1 years, disease duration was 10.7 (1–38) years. According to CT findings of 120 patients, 35% had nodules, and 13.3% had ILD (62.5% nonspecific interstitial pneumonia, 25% lymphocytic interstitial pneumonia, 12.5% usual interstitial pneumonia). Bronchiectasis, emphysema, sequelae fibrotic changes, and pleural thickening was found in 3.3%, 5.8%, 15.8%, and 1.7% of patients, respectively. It was observed that there was a significant relationship between the presence of ILD and persistent cough, mediastinal LAP, low DLCO, high ESSDAI and clin-ESSDAI scores reflecting disease activity. CONCLUSION: The most common pulmonary manifestation in our patients was ILD. ILD was observed more frequently in patients with moderate and severe disease activity. Some of the ILD patients were diagnosed while they were asymptomatic. Even if they are asymptomatic, it is important to follow up the patients with physical examination, spirometry, DLCO and thorax CT. Scientific and Technological Research Council of Turkey (TUBITAK) 2022-04-19 /pmc/articles/PMC10395710/ /pubmed/36422505 http://dx.doi.org/10.55730/1300-0144.5513 Text en © TÜBİTAK https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
ÖZDEMİR IŞIK, Özlem
YAZICI, Ayten
ÇEFLE, Ayşe
The respiratory manifestations in patients with primary Sjögren’s syndrome: is interstitial lung disease related to disease activity?
title The respiratory manifestations in patients with primary Sjögren’s syndrome: is interstitial lung disease related to disease activity?
title_full The respiratory manifestations in patients with primary Sjögren’s syndrome: is interstitial lung disease related to disease activity?
title_fullStr The respiratory manifestations in patients with primary Sjögren’s syndrome: is interstitial lung disease related to disease activity?
title_full_unstemmed The respiratory manifestations in patients with primary Sjögren’s syndrome: is interstitial lung disease related to disease activity?
title_short The respiratory manifestations in patients with primary Sjögren’s syndrome: is interstitial lung disease related to disease activity?
title_sort respiratory manifestations in patients with primary sjögren’s syndrome: is interstitial lung disease related to disease activity?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395710/
https://www.ncbi.nlm.nih.gov/pubmed/36422505
http://dx.doi.org/10.55730/1300-0144.5513
work_keys_str_mv AT ozdemirisikozlem therespiratorymanifestationsinpatientswithprimarysjogrenssyndromeisinterstitiallungdiseaserelatedtodiseaseactivity
AT yaziciayten therespiratorymanifestationsinpatientswithprimarysjogrenssyndromeisinterstitiallungdiseaserelatedtodiseaseactivity
AT cefleayse therespiratorymanifestationsinpatientswithprimarysjogrenssyndromeisinterstitiallungdiseaserelatedtodiseaseactivity
AT ozdemirisikozlem respiratorymanifestationsinpatientswithprimarysjogrenssyndromeisinterstitiallungdiseaserelatedtodiseaseactivity
AT yaziciayten respiratorymanifestationsinpatientswithprimarysjogrenssyndromeisinterstitiallungdiseaserelatedtodiseaseactivity
AT cefleayse respiratorymanifestationsinpatientswithprimarysjogrenssyndromeisinterstitiallungdiseaserelatedtodiseaseactivity